摘要
【目的】研究碳酸酐酶Ⅸ(CAⅨ)和低氧诱导因子1α(HIF-1α)在非小细胞肺癌(NSCLC)中的表达及意义。【方法】检测80例NSCLC手术标本中的CAⅨ和HIF-1α表达,分析其在癌组织中表达与临床、病理之间的关系。【结果】NSCLC中CAⅨ和HIF1α的表达率分别为71.25%及66.25%,均显著高于正常肺组织(P〈0.01)。CAⅨ在NSCLC的表达与患者临床特征、病理类型无关(P〉0.05),但CAⅨ在淋巴结转移组的阳性表达率明显高于无淋巴结转移组(P〈0.05);TNM分期Ⅲ~Ⅳ期的cAⅨ阳性表达率高于TNMⅠ~Ⅱ期的CAⅨ阳性表达率(P〈0.05)。而HIF-1α在NSCLC中的表达与患者临床特征、病理类型和临床分期及淋巴结转移均无关(P〉0.05);CAⅨ和HIF-1α在非小细胞肺癌组织中的表达相关性不强(P〉0.05)。【结论】CAIX参与了NSCLC的发生、发展和侵袭转移,其可能成为抗肿瘤的新靶点。
[Objective] To investigate the expression of carbonic anhydrase Ⅸ(CA Ⅸ ) and hypoxia induc ible factor-1α(HIF-1α) in non-small cell lung cancer(NSCLC) and its significance. [Methods]The expressions of CA ⅨX and HIF-1α in surgical specimens of 80 patients with NSCLC were measured. The relationship of the expressions with clinical features and pathology was analyzed. [Results]The expression of CA Ⅸ and HIF-1α in NSCLC was 71.25% and 66.25 %, respectively, which were significantly higher than those in normal lung tissues( P 〈0.01). The expression of CA Ⅸ in NSCLC had no correlation with clinical features and patholog- ical types( P 〉0. 05), but the positive expression of CA Ⅸ in lymph node metastasis group was obviously higher than that in non-metastasis group( P 〈0.05). The positive expression of CA Ⅸ in stage TⅢ -Ⅳ was higher than that in stage TⅠ-Ⅲ( P 〈0.05). The expression of HIF-1αin NSCLC had no correlation with clinical features, pathological types, clinical stage and lymph node metastasis( P 〉0.05). The correlation be- tween CA Ⅸ and HIF-1α in NSCLC tissue is not strong( P〉0.05). [Conclusion]CA Ⅸ involves in the path- ogenesis, development, invasion and metastases of MSCLC, and may be a new target of antitumor therapy.
出处
《医学临床研究》
CAS
2012年第7期1228-1230,1234,共4页
Journal of Clinical Research